Proapoptotic activity of fluphenazine analogues after blocking sphinogomyelinases in cultures of human lymphocytes

Onkologia Polska

Volumn 14, Issue 2, 2011, Pages 54-63

  Jaszczyszyn, Agata ^a   Gaşiorowski, Kazimierz ^a   Sẃiaţek, Piotr ^a   Malinka, Wiesałw ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Apoptosis; Ceramide; Fluphenazine analogues; Sphingomyelinases

Indexed keywords

BENZO[A]PYRENE; CASPASE 3; CERAMIDE; FLUPHENAZINE; PHENOTHIAZINE; SPHINGOMYELIN PHOSPHODIESTERASE;

APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; COLORIMETRY; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LIPOPHILICITY; LYMPHOCYTE CULTURE;

EID: 80054963871     PISSN: 15056732     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Matsuyama R., Reddy S., Smith T.J.: Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J. Clin. Oncol., 2006, 24, 3490-3496. (Pubitemid 46638908)
2. Taheri M., Mahjoubi F., Omranipour R.: Effect of MDR1 polymorphism on multidrug resistance expression In breast cancer patients. Genet. Mol. Res., 2010, 9, 34-40.
3. Chai S., To K., Lin G.: Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines. Chin. Medicine, 2010, 5, 26-34.
4. Park S.J., Bijangi-Vishehsaraei K., Safa A.R.: Selective TRAIL-triggered apoptosis due to overepression of TRAIL death receptor 5 (DR5) in P-glycoprotein-bearing multidrug resistant CEM/VBL1000 human leukemia cells. Int. J. Biochem. Mol. Biol., 2010, 1, 90-100.
5. Bielak-Żmijewska A.: Mechanizmy oporności komórek nowotworowych na apoptozȩ. Kosmos. Problemy Nauk Biologicznych, 2003, 52, 157-171.
6. Smolewski P., Grzybowska O.: Regulacja procesu apoptozy komórek w celach terapeutycznych - dotychczasowe doświadczenia i perspektywy rozwoju. Acta Haematol. Pol., 2002, 33, 393-401. (Pubitemid 36172805)
7. Lin Y.Y., Yu J.Y., Yih D. et al.: A role for ceramide in driving cancer cell resistance to doxorubicin. FASEB J. 2008, 22, 2541-2551.
8. Pettus B.J., Chalfant Ch.E., Hanhun Y.A.: Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophys. Acta. 2002, 1585, 114-125. (Pubitemid 36092075)
9. Meacham W.D., Antoon J.W., Burow M.E. et al.: Sphingolipids as determinants of apoptosis and chemoresistance in the MCF-7 cell model system. Exp. Biol. Med., 2009, 234, 1253-1263.
10. Duan R.D., Bergman T., Xu N. et al.: Identification of human intestinal alkaline phingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family. J. Biol. Chem., 2003, 278, 38528-38536. (Pubitemid 37221748)
11. Sawai A., Domae N., Nagan N., Hannun Y.A.: Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor - phospholipase C. J. Biol. Chem., 1999, 274, 38131-38139. (Pubitemid 30026885)
12. Gulbins E.: Regulation of death receptor signaling and apoptosis by ceramide. Pharmacol. Res., 2003, 47, 393-399.
13. Dobrek Ł., Szczȩśniak P., Thor P., Orszulak-Michalak D.: Aktualne kierunki w poszukiwaniach nowych leków przeciwnowotworowych. Geriatria, 2008, 2, 37-42.
14. Gil-Ad I., Shtaif B., Levkovitz Y. et al.: Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Oncol. Rep., 2006, 15, 107-112.
15. Bisi A., Meli M., Gobbi S. et al.: Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives. Bioorg. Med. Chem., 2008, 16, 6474-6482. (Pubitemid 351794257)
16. Kolesnick R.N., Hemer M.R.: Trifluoperazine stimulates the coordinate degradation of shingomyelin and phosphatidylocholine in GH3 pituitary cells. J. Biol. Chem., 1989, 264, 14057-14061. (Pubitemid 19214231)
17. Jaffrézou J.P., Chen G., Durán G.E. et al.: Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance. Biochem. Biophys. Acta, 1995, 1266, 1-8.
18. Jaszczyszyn A., Ga̧siorowski K.: Historia zastosowań klinicznych pochodnych fenotiazyny. [in:] Antropologia medycyny i farmacji w kontekście kulturowym, społecznym i historycznym. Studia Humanistyczne Wydziału Farmaceutycznego Akademii Medycznej we Wrocławiu. t. 1. B. Płonka-Syroka (ed.), AM we Wrocławiu, Wrocław 2008, 273-284.
19. Ga̧siorowski K.: Antimutagenic activity of todralazine and fluphenazine. A comparison of the results from short-term cytogenetic tests. Cell. Biol. Mol. Lett. 2000, 5, 397-403.
20. Ga̧siorowski K., Malinka W., Świa̧tek P., Jaszczyszyn A.: Antimutagenic activity of new analogues of fluphenazine. Cell Mol. Biol. Lett., 2003, 8, 927-942. (Pubitemid 38095069)
21. Jaszczyszyn A., Ga̧siorowski K.: Mechanizmy chemoprewencyjnego działania nowo syntezowanych analogów flufenazny. Borgis, Warszawa 2006.
22. Ga̧siorowski K., Jaszczyszyn A.: Fenotiazyny w paliatywnej terapii nowotworów. Onkol. Pol., 2008, 11, 167-172.
23. Levinson D.F., Simpson G.M., Lo E.S. et al.: Fluphenazine plasma levels, dosage, efficacy, and side effects. Am. J. Psychiatry, 1995, 152, 765-771.
24. De Ruiter J.: Dopamine antagonists: phenothiazine/thioxanthene sar. [in:] Principles of drug action: The basis of pharmacology. W.B. Pratt, P. Taylor (ed.), Churchill Livingstone, New York 1990, 1-14.
25. Mahar Doan K.M., Humphreys J.E., Webster L.O. et al.: Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. J. Pharmacol. Exp. Ther., 2002, 303, 1029-1037. (Pubitemid 35424386)
26. Jaszczyszyn A., Ga̧siorowski K., Świa̧tek P., Malinka W.: Wpływ nowo syntezowanych analogów flufenazyny na apoptozȩ i nekrozȩ w hodowlach limfocytów. Onkol. Pol., 2009, 12, 121-127.
27. Elmore S.: Apoptosis: a review of programmed cell death. Toxicol. Pathol., 2007, 35, 495-516.
28. Liu B., Hannun Y.A.: Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J. Biol. Chem., 1997, 272, 16281-16287. (Pubitemid 27276449)
29. Gomez-Muñoz A., Kong J.Y., Salh B., Steinbrecher P.U.: Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages. J. Lipid Res., 2004, 45, 99-105. (Pubitemid 38176619)
30. Liu J.J., Wang J.Y., Hertervig E. et al.: Activation of neutral sphingomyelinase participates in ethanol-induced apoptosis in Hep G2 cells. Alcohol Alcohol., 2000, 35, 569-573.
31. Takeda Y., Tashima M., Takahashi A. et al.: Ceramide generation in nitric oxide-induced apoptosis. Activation of magnesium-dependent neutral sphingomyelinase via caspase-3. J. Biol. Chem., 1999, 274, 10654-10660.